Binah Capital Group Inc. (O1Y)
XFRA 
Summary
CG Oncology Undervalued Going Into A Busy 2026
CG Oncology is positioned as a leading contender in high-risk BCG-unresponsive NMIBC, with its oncolytic adenovirus, cretostimogene grenadenorepvec (creto). Creto's efficacy and safety data rival JNJ's Inlexo, with a 75.5% any-time CR rate, similar 12mo/24mo CR rates, a longer response duration, and notably fewer Grade 3+ adverse events. CGON targets $2B peak revenue in its primary indication, with meaningful upside from intermediate-risk, BCG-naïve, and muscle-invasive bladder cancer opportunities.
1 Stock-Split AI Stock to Buy Before It Soars 450%, According to a Wall Street Expert
Philip Panaro is a founder and former CEO of Boston Consulting Group (BCG) Platinion, a division of BCG that offers technology consulting services. During an interview in November, Panaro told Schwab Network that Nvidia (NVDA -1.81%) could hit $800 per share by 2030 due to its leadership in artificial intelligence (AI) accelerators.
Binah Capital Group Inc. (O1Y) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Binah Capital Group Inc. ever had a stock split?
Binah Capital Group Inc. Profile
| Capital Markets Industry | Financials Sector | Craig Michael Gould CEO | XFRA Exchange | US09032H1059 ISIN |
| US Country | 150 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Binah Capital Group, Inc. is a distinguished entity within the wealth management sector, incorporating its expertise through a comprehensive subsidiary network. Founded in the vibrant economic landscape of 2016 and anchored in Albany, New York, the company has rapidly ascended within the financial services realm. As a pivotal subsidiary of MHC Securities, LLC, Binah Capital Group embarks on a mission to furnish an extensive array of financial services tailored to meet the intricate demands of today’s investors and financial advisors. The essence of its operation lies in delivering unparalleled access to a spectrum of execution services alongside vital support functions including research, compliance, and a suite of related services indispensable for financial professionals navigating the complexities of modern investment avenues.
Products and Services
The offerings from Binah Capital Group, Inc. span a comprehensive range of financial products and services designed to cater to the diverse needs of investors and financial advisors alike:
- Stock, Bond, Exchange-Traded Fund, and Options Execution Services: Binah Capital Group provides robust platforms and tools for the execution of trades across a wide array of investment vehicles, ensuring clients have seamless access to capital markets.
- Research, Compliance, Supervision, and Accounting and Related Services: To support financial advisors in their practice management, Binah Capital Group offers a suite of services including market research, compliance oversight, supervisory protocols, and accounting services, thereby ensuring that advisors can maintain focus on client outcomes while navigating regulatory frameworks.
- Mutual Funds and Insurance Products: The company provides a plethora of mutual fund options along with various insurance products, catering to investors seeking diversified investment solutions and financial protection mechanisms.
- Alternative Investments: For clients looking towards non-traditional investment avenues, Binah Capital Group offers investments such as non-traded real estate investment trusts (REITs), unit trusts, and both fixed and variable annuities, enriching the investment portfolio with options that extend beyond conventional market instruments.
